Medicinal applications of fullerenes

Fullerenes have attracted considerable attention in different fields of science since their discovery in 1985. Investigations of physical, chemical and biological properties of fullerenes have yielded promising information. It is inferred that size, hydrophobicity, three-dimensionality and electronic configurations make them an appealing subject in medicinal chemistry. Their unique carbon cage structure coupled with immense scope for derivatization make them a potential therapeutic agent. The study of biological applications has attracted increasing attention despite the low solubility of carbon spheres in physiological media. The fullerene family, and especially C60, has appealing photo, electrochemical and physical properties, which can be exploited in various medical fields. Fullerene is able to fit inside the hydrophobic cavity of HIV proteases, inhibiting the access of substrates to the catalytic site of enzyme. It can be used as radical scavenger and antioxidant. At the same time, if exposed to light, fullerene can produce singlet oxygen in high quantum yields. This action, together with direct electron transfer from excited state of fullerene and DNA bases, can be used to cleave DNA. In addition, fullerenes have been used as a carrier for gene and drug delivery systems. Also they are used for serum protein profiling as MELDI material for biomarker discovery. In this review we report the aspects of medicinal applications of fullerenes.

[1]  Harold W. Kroto,et al.  Isolation, separation and characterisation of the fullerenes C60 and C70 : the third form of carbon , 1990 .

[2]  S. C. O'brien,et al.  C60: Buckminsterfullerene , 1985, Nature.

[3]  H. Okayama,et al.  Synthesis and Transfection Capability of Multi-Functionalized Fullerene Polyamine , 2001 .

[4]  W. Malorni,et al.  C3‐Fullero‐tris‐Methanodicarboxylic Acid Protects Cerebellar Granule Cells from Apoptosis , 2000, Journal of neurochemistry.

[5]  A. Hirsch,et al.  Cytotoxicity and photocytotoxicity of a dendritic C(60) mono-adduct and a malonic acid C(60) tris-adduct on Jurkat cells. , 2002, Journal of photochemistry and photobiology. B, Biology.

[6]  G. Miller,et al.  Nanobionics of Pharmacologically Active Derivatives of Fullerene C60 , 2003 .

[7]  W. Krätschmer,et al.  Solid C60: a new form of carbon , 1990, Nature.

[8]  J. Tour,et al.  Synthesis of 14C-Labeled C60, Its Suspension in Water, and Its Uptake by Human Keratinocytes , 1994 .

[9]  Michael R Hamblin,et al.  Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. , 2007, Free radical biology & medicine.

[10]  A. Hirsch,et al.  Regiochemistry of Multiple Additions to the Fullerene Core: Synthesis of a Th-Symmetric Hexakis adduct of C60 with Bis(ethoxycarbonyl)methylene , 1994 .

[11]  S. Mirzadeh,et al.  TOWARD FULLERENE-BASED RADIOPHARMACEUTICALS : HIGH-YIELD NEUTRON ACTIVATION OF ENDOHEDRAL 165HO METALLOFULLERENES , 1999 .

[12]  Aibing Yu,et al.  Inorganic nanoparticles as carriers for efficient cellular delivery , 2006 .

[13]  Eiichi Nakamura,et al.  Functionalized Fullerenes in Water. The First 10 Years of Their Chemistry, Biology, and Nanoscience , 2004 .

[14]  C. Bonfils,et al.  Cellular localisation of a water-soluble fullerene derivative. , 2002, Biochemical and biophysical research communications.

[15]  Y. H. Chen,et al.  Polyhydroxylated C60, Fullerenol, a Novel Free‐radical Trapper, Prevented Hydrogen Peroxide‐ and Cumene Hydroperoxide‐elicited Changes in Rat Hippocampus In‐vitro , 1997, The Journal of pharmacy and pharmacology.

[16]  F. Käsermann,et al.  Photodynamic inactivation of enveloped viruses by buckminsterfullerene. , 1997, Antiviral research.

[17]  A. Domb,et al.  Current developments in gene transfection agents. , 2004, Current drug delivery.

[18]  K. O’Malley,et al.  Distinct Mechanisms Underlie Neurotoxin-Mediated Cell Death in Cultured Dopaminergic Neurons , 1999, The Journal of Neuroscience.

[19]  L. Chiang,et al.  Acute and Subacute Toxicity Study of Water-Soluble Polyalkylsulfonated C60 in Rats , 1998, Toxicologic pathology.

[20]  T. Mashino,et al.  Inhibitory effects of a fullerene derivative, dimalonic acid C60, on nitric oxide-induced relaxation of rabbit aorta. , 1997, European journal of pharmacology.

[21]  T. Yagami,et al.  Solubilization of fullerenes into water with polyvinylpyrrolidone applicable to biological tests , 1994 .

[22]  H. Kroto,et al.  C 60 Buckminsterfullerene , 1990 .

[23]  K. Preston,et al.  Radical Reactions of C60 , 1991, Science.

[24]  K. Suenaga,et al.  Production, Isolation, and EELS Characterization of Ti2@C84 Dititanium Metallofullerenes , 2002 .

[25]  Shuqing Sun,et al.  Recent progress in the studies of endohedral metallofullerenes , 2000 .

[26]  B. Coursey,et al.  ENCAPSULATION OF 99MTC WITHIN FULLERENES : A NOVEL RADIONUCLIDIC CARRIER , 1997 .

[27]  Mark E Tuckerman,et al.  Molecular dynamics study of the connection between flap closing and binding of fullerene-based inhibitors of the HIV-1 protease. , 2003, Biochemistry.

[28]  Charles L. Wilkins,et al.  Synthesis of a Fullerene Derivative for the Inhibition of HIV Enzymes. , 1993 .

[29]  M. Prato,et al.  Biological Applications of Fullerene Derivatives: A Brief Overview , 2001 .

[30]  M. Reid,et al.  Selective protection against IgG binding to red cells treated with phthalocyanines and red light for virus inactivation , 1995, Transfusion.

[31]  A new analytical material-enhanced laser desorption ionization (MELDI) based approach for the determination of low-mass serum constituents using fullerene derivatives for selective enrichment. , 2007, Journal of proteome research.

[32]  E. Nakamura,et al.  In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. , 1995, Chemistry & biology.

[33]  C. Huck,et al.  Ultra-fast mass fingerprinting by high-affinity capture of peptides and proteins on derivatized poly(glycidyl methacrylate/divinylbenzene) for the analysis of serum and cell lysates. , 2006, Rapid communications in mass spectrometry : RCM.

[34]  A. Hirsch,et al.  A highly water-soluble dendro[60]fullerene , 1998 .

[35]  Li Xiao,et al.  The water-soluble fullerene derivative "Radical Sponge" exerts cytoprotective action against UVA irradiation but not visible-light-catalyzed cytotoxicity in human skin keratinocytes. , 2006, Bioorganic & medicinal chemistry letters.

[36]  Shen,et al.  Carboxyfullerenes as neuroprotective agents. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Balch,et al.  A symmetric derivative of the trimetallic nitride endohedral metallofullerene, Sc3N@C80. , 2002, Journal of the American Chemical Society.

[38]  N. Cue,et al.  Isolation and characterization of a new metallofullerene Nd@C82 , 1996 .

[39]  T. Yagami,et al.  Acridine Adduct of [60]Fullerene with Enhanced DNA-Cleaving Activity. , 1996, The Journal of organic chemistry.

[40]  Ya-Wen Chen,et al.  Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[41]  H. Okayama,et al.  Nonviral gene delivery by tetraamino fullerene. , 2006, Molecular pharmaceutics.

[42]  R. Bensasson,et al.  C60 in Model Biological Systems. A Visible-UV Absorption Study of Solvent-Dependent Parameters and Solute Aggregation , 1994 .

[43]  A. Hirsch,et al.  Fullerenes in membranes: Structural and dynamic effects of lipophilic C60 derivatives in phospholipid bilayers , 1997 .

[44]  N. Monteiro-Riviere,et al.  Penetration of intact skin by quantum dots with diverse physicochemical properties. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[45]  A. Fisher,et al.  Small-bandgap endohedral metallofullerenes in high yield and purity , 1999, Nature.

[46]  S. Miertus,et al.  Design and synthesis of novel [60]fullerene derivatives as potential HIV aspartic protease inhibitors. , 2000, Organic letters.

[47]  Yukihiro Goda,et al.  Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2-* versus 1O2. , 2003, Journal of the American Chemical Society.

[48]  C. Franceschi,et al.  C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells. , 2000, Biochemical and biophysical research communications.

[49]  V. Knight,et al.  A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture. , 2005, Journal of the American Chemical Society.

[50]  L. Ho,et al.  Local carboxyfullerene protects cortical infarction in rat brain , 2002, Neuroscience Research.

[51]  T. Tsuchiya,et al.  A novel promoting action of fullerene C60 on the chondrogenesis in rat embryonic limb bud cell culture system. , 1995, Biochemical and biophysical research communications.

[52]  M. Prato,et al.  Anti-HIV properties of cationic fullerene derivatives. , 2005, Bioorganic & medicinal chemistry letters.

[53]  C. Franceschi,et al.  C3‐Fullero‐tris‐methanodicarboxylic acid protects epithelial cells from radiation‐induced anoikia by influencing cell adhesion ability , 1999, FEBS letters.

[54]  T. Slater,et al.  Carbon tetrachloride toxicity as a model for studying free-radical mediated liver injury. , 1985, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[55]  Barry Halliwell,et al.  Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.

[56]  Jan Balzarini,et al.  Synthesis and anti-HIV properties of new water-soluble bis-functionalized[60]fullerene derivatives. , 2003, Bioorganic & medicinal chemistry letters.

[57]  Y. Yamakoshi,et al.  A highly water-soluble C60-NVP copolymer: a potential material for photodynamic therapy. , 2006, Chemical communications.

[58]  C. Chou,et al.  Blockage of apoptotic signaling of transforming growth factor-beta in human hepatoma cells by carboxyfullerene. , 1998, European journal of biochemistry.

[59]  J. West,et al.  The Differential Cytotoxicity of Water-Soluble Fullerenes , 2004 .

[60]  H. Okayama,et al.  Gene delivery by aminofullerenes: structural requirements for efficient transfection. , 2006, Chemistry, an Asian journal.

[61]  Shinobu Ito,et al.  Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis. , 2006, Toxicology.

[62]  T. Luh,et al.  Carboxyfullerene Prevents Iron‐Induced Oxidative Stress in Rat Brain , 1999, Journal of neurochemistry.

[63]  Fred Wudl,et al.  Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification , 1993 .

[64]  A. Guttman,et al.  Material-enhanced laser desorption/ionization (MELDI)—A new protein profiling tool utilizing specific carrier materials for time of flight mass spectrometric analysis , 2006, Journal of the American Society for Mass Spectrometry.

[65]  Nancy A Monteiro-Riviere,et al.  Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. , 2007, Nano letters.

[66]  R. Cai,et al.  Synthesis and characterization of fullerol derived from C 60 n- precursors , 2001 .

[67]  Hongfang Sun,et al.  Biodistribution and tumor uptake of C60(OH)x in mice , 2006 .

[68]  V. Romanova,et al.  Addition of amino acids and dipeptides to fullerene C60 giving rise to monoadducts , 1994 .

[69]  Y. Rubin,et al.  Sequence-specific modification of guanosine in DNA by a C60-linked deoxyoligonucleotide: Evidence for a non-singlet oxygen mechanism , 1996 .

[70]  H. Kroto,et al.  Isolation, Separation, and Characterization of the Fullerenes C60 and C70: The Third Form of Carbon. , 1991 .

[71]  M. Prato,et al.  Synthesis, Chiroptical Properties, and Configurational Assignment of Fulleroproline Derivatives and Peptides , 1996 .

[72]  Maurizio Prato,et al.  [60]Fullerene chemistry for materials science applications , 1997 .

[73]  N. Nitta,et al.  Preparation of PEG-conjugated fullerene containing Gd3+ ions for photodynamic therapy. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[74]  Stephen R. Wilson,et al.  [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. , 2005, Nano letters.